Skip to main content
Clinical Trials/NCT03860194
NCT03860194
Completed
Not Applicable

Effects of Adequate Dietary Protein With Whey Protein, Leucine, and Vitamin D Supplementation on Sarcopenia in Elderly Subjects:An Open-label, Parallel-group Study

Far Eastern Memorial Hospital1 site in 1 country85 target enrollmentMarch 22, 2017
ConditionsSarcopenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
Far Eastern Memorial Hospital
Enrollment
85
Locations
1
Primary Endpoint
Handgrip strength
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Sarcopenia is defined as a syndrome characterized by decline of skeletal muscle mass and strength or an alteration in physical function. Although some studies showed nutritional supplementation alone might have health benefits for older sarcopenic patients, the results were inconsistent and remain controversial. The objective of this study was to evaluate if a sufficient protein diet including supplements with leucine-enriched whey protein and vitamin D can lead to better improvement than sufficient dietary protein alone in maintaining muscle mass and strength among sarcopenic elders.

Registry
clinicaltrials.gov
Start Date
March 22, 2017
End Date
December 30, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chih-Chien Lin

Attending physician of the Family Medicine Department, Principal Investigator

Far Eastern Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • Older adults (≥ 65 years)
  • Subject has lower appendicular muscle mass index (AMMI) (\<7 kg/m\^2 in men; \<5.7 kg/m\^2 in women) using Bioelectrical impedance analysis (BIA, TANITA BC-418®, Tokyo, Japan)
  • Subject has lower handgrip strength (\<26 kg in men; \<18 kg in women) using dynamometer (CAMRY®, Zhongshan, Guangdong) or slowly gait speed (\<1 m/s)

Exclusion Criteria

  • Subject's life expectancy was shorter than 6 months
  • Nursing home resident
  • Subject has the history of kidney failure
  • Subject has the history of liver failure
  • Subject has the history of diabetes mellitus
  • Subject has resistance exercise habit.

Outcomes

Primary Outcomes

Handgrip strength

Time Frame: Change measures (baseline and 4 weeks, baseline and 12 weeks)

Hand dynamometer was used to measure handgrip strength. Subject was asked to sit in an upright position with the upper arm forming a virtually 90 degree angle with the forearm. Three consecutive measurements of grip strength obtained from both hands were recorded and average of the highest value was calculated as the maximum grip strength. The unit of handgrip strength was represented as kilogram.

AMMI(appendicular muscle mass index)

Time Frame: Change measures (baseline and 4 weeks, baseline and 12 weeks)

Bioelectrical impedance analysis was used to obtain appendicular muscle mass (AMM) and height. The unit of AMM and height were represented as kilogram and meter respectively. AMMI were calculated as AMM/height\^2 (kg/m\^2).

Gait speed

Time Frame: Change measures (baseline and 4 weeks, baseline and 12 weeks)

Asking the subjects to perform a 5-meter walk at their usual pace and measure how much second they could complete this distance, then the unit of gait speed was represented as m/s.

Study Sites (1)

Loading locations...

Similar Trials